Intravenous Infusions (XGHA:IIL) EPS (Diluted): GHS (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Intravenous Infusions EPS (Diluted)?

Intravenous Infusions XGHA:IIL +8.86% EPS (Diluted) is GHS as of . 20.

Intravenous Infusions's Earnings per Share (Diluted) for the six months ended in . 20 was GHS0.00.

Intravenous Infusions's EPS (Basic) for the six months ended in . 20 was GHS0.00.

Intravenous Infusions's EPS without NRI for the six months ended in . 20 was GHS0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Intravenous Infusions  (XGHA:IIL) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Intravenous Infusions EPS (Diluted) Related Terms

Intravenous Infusions EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions EPS (Diluted) Chart

Intravenous Infusions Annual Data
Trend
EPS (Diluted)

Intravenous Infusions Semi-Annual Data
EPS (Diluted)

XGHA:IIL vs PTLF, PCYN, YBAO: EPS (Diluted) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's PE Ratio distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's PE Ratio falls into.


Intravenous Infusions EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Intravenous Infusions's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Intravenous Infusions's Diluted EPS for the quarter that ended in . 20 is calculated as

Diluted EPS (Q: . 20 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of GHS mean?
Intravenous Infusions (XGHA:IIL) has a EPS (Diluted) of GHS as of . 20. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' EPS (Diluted) too high?
Intravenous Infusions' current EPS (Diluted) is GHS.
How does Intravenous Infusions' EPS (Diluted) compare to PTLF and PCYN?
Intravenous Infusions' EPS (Diluted) of GHS can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current EPS (Diluted) is GHS. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current EPS (Diluted) of GHS. The current EPS (Diluted) is GHS. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current EPS (Diluted) is GHS as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.